Satellite Cell Biology and In Vitro Meat Production: From Muscle Stem Cell Niche to Commercial Scalability

Abstract

Cultured meat — skeletal muscle tissue produced by the controlled proliferation and differentiation of muscle stem cells (satellite cells, SCs) outside the living animal — has transitioned from a speculative concept to a commercially approved food product within less than a decade, driven by growing global concern over the environmental sustainability, animal welfare implications, and pandemic risk potential of industrial livestock production. The first cultured beef burger, presented publicly by Mark Post in 2013, cost approximately €250,000 to produce; by 2020, cost estimates from commercial developers had fallen to the range of $10-50/kg, and Singapore had approved Eat Just's cultured chicken product for commercial sale. This review comprehensively examines the biology of satellite cells as the primary cellular substrate for cultured meat production, including their quiescent niche regulation, activation signalling cascades (HGF, FGF2, IGF-1, Notch/Wnt), in vitro proliferation kinetics, and differentiation into multinucleated myotubes. Critical process engineering challenges are systematically addressed: formulation of serum- free, food- safe culture media; scaffold materials enabling three- dimensional myotube organisation and maturation; bioreactor configurations suitable for scale- up to commercial production volumes; strategies for adipocyte integration to replicate the fat content of conventional meat; and the use of iPSC- derived myogenic cells to overcome the proliferative senescence of primary satellite cells. The review also addresses lifecycle assessment data comparing cultured meat's environmental footprint with conventional beef, pork, and chicken; regulatory approval pathways in the United States, European Union, and Singapore; and consumer acceptance research, with a particular focus on the factors that will determine the pace of mainstream market adoption.